BAUSCH + LOMB CORP (BLCO.CA) Stock News
TSX:BLCO - Toronto Stock Exchange - CA0717051076 - Common Stock - Currency: CAD
BLCO.CA Latest News, Press Relases and Analysis
All
Press Releases
12 days ago - Bausch + Lomb Corporation
Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference
Mentions: BLCO
13 days ago - Bausch + Lomb Corporation
Bausch + Lomb Announces 2025 Annual Meeting of Shareholders Results
Mentions: BLCO
13 days ago - Bausch + Lomb Corporation
Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States
Mentions: BLCO
20 days ago - Bausch + Lomb Corporation
Bausch + Lomb Launches Zenlens® CHROMA HOA™ in the United States
Mentions: BLCO
a month ago - Bausch + Lomb Corporation
Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens
Mentions: BLCO
a month ago - Bausch + Lomb Corporation
Bausch + Lomb Announces First-Quarter 2025 Results
Mentions: BLCO
a month ago - Bausch + Lomb Corporation
Bausch + Lomb Returning enVista® Intraocular Lenses to Market Following Voluntary Recall
Mentions: BLCO
2 months ago - Bausch + Lomb Corporation
Bausch + Lomb Announces Voluntary Recall of enVista Aspire™, enVista Envy™ and Certain enVista® Monofocal Intraocular Lenses
Mentions: BLCO
2 months ago - Bausch + Lomb Corporation
Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30
Mentions: BLCO
3 months ago - Bausch + Lomb Corporation
Bausch + Lomb Launches Arise™ Orthokeratology Lens System in the United States
Mentions: BLCO
3 months ago - Bausch + Lomb Corporation
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 Guidance
Mentions: BLCO
4 months ago - Bausch + Lomb Corporation
Bausch + Lomb Provides Update on Potential Sale
Mentions: BLCO
4 months ago - Bausch + Lomb Corporation
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19
Mentions: BLCO
5 months ago - Bausch + Lomb Corporation
Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences
Mentions: BLCO
5 months ago - Bausch + Lomb Corporation
Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union
Mentions: BLCO
5 months ago - Bausch + Lomb Corporation
Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge
Mentions: BLCO
5 months ago - Bausch + Lomb Corporation
Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Mentions: BLCO
6 months ago - Bausch + Lomb Corporation
Bausch + Lomb Responds to Rumors of a Potential Sale
Mentions: BLCO
6 months ago - Bausch + Lomb Corporation
Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities
Mentions: BLCO
7 months ago - Bausch + Lomb Corporation
Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs
Mentions: BLCO
7 months ago - Bausch + Lomb Corporation
Bausch + Lomb Announces Third-Quarter 2024 Results
Mentions: BLCO
8 months ago - Bausch + Lomb Corporation
Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens
Mentions: BLCO
8 months ago - Bausch + Lomb Corporation
Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30
Mentions: BLCO
8 months ago - Bausch + Lomb Corporation
Bausch + Lomb Launches Opal™ Digital Marketplace in the United States
Mentions: BLCO
10 months ago - Bausch + Lomb Corporation
Bausch + Lomb Announces Second-Quarter 2024 Results
Mentions: BLCO
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31
Mentions: BLCO
a year ago - Bausch + Lomb Corporation
Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief
Mentions: BLCO
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress
Mentions: BLCO
a year ago - Bausch + Lomb Corporation
Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States
Mentions: BLCO
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States
Mentions: BLCO
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results
Mentions: BLCO
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®
Mentions: BLCO
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens
Mentions: BLCO
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Announces First-Quarter 2024 Results
Mentions: BLCO
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting
Mentions: BLCO
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes
Mentions: BLCO
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs
Mentions: BLCO
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1
Mentions: BLCO
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting
Mentions: BLCO
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors
Mentions: BLCO